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WWOX is comprised of 9 coding exons in a region of 
approximately one million base pairs that includes the 
common fragile site FRA16D. 
Transcription 
RT-PCR amplification of Wwox in normal and tumor 
cDNA samples has shown products apparently 
originating from alternative transcripts or transcript 
variants, respectively. Expressed truncated proteins 





WWOX is a 414 amino acid protein that contains two 
WW domains and a short-chain 
dehydrogenase/reductase (SDR) domain. 
Expression 
WWOX is highly expressed in secretory epithelial cells  
of reproductive, endocrine and exocrine organs and is 
expressed in all or most other tissues at a lower level. 
The protein is not expressed or is expressed at low level 
in many tumor types, including breast, pancreatic, 
gastric, hepatocellular, ovarian, lung and prostate 
cancers. Loss of WWOX expression can be due to 
inactivation by promoter methylation, allelic deletion 




Contains an N-terminal group 1 WW domain that binds 
proteins with a PPXY motif. Reportedly interacts with 
p53, p73, JUN, ERBB4, Ap2alpha, Ap2gamma, 
Ezrin/VIL2, Ack1/TNK2. Probably involved in 
apoptosis, steroid (estrogen) metabolism and signaling 
pathways. Mice carrying a targeted deletion of the 
Wwox gene develop osteosarcomas in juvenile Wwox(-
/-) and lung papillary carcinomas in adult Wwox(+/-) 
mice spontaneously. Wwox(+/-) mice develop 
significantly more ethyl nitrosourea-induced lung 
tumors and lymphomas than wild-type littermates. 
Mutations 
Somatic 
Cancer cell lines from various tumor types, including 
ovarian, gastric and pancreatic, exhibit deletions within 
the WWOX gene, frequently in the introns surrounding 
exon 8. 
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Alignment of human (hWwox), mouse (Mwwox), fly (fWwox), mosquito (moWwox) and worm (ceWwox) Wwox proteins. The locations of 
the WW1 and WW2 domains are shown, as well as the predicted sites for nuclear localization, NADP binding, mitochondrial targeting, 
substrate binding and a proton acceptor. 
 
Implicated in 
Breast cancer, esophageal and non-
small cell lung cancer 
Disease 
Breast, esophageal and non-small cell lung cancer show 
high LOH rates and low mutation rates. 27% of ER+ 
breast carcinomas versus 46% for ER- cases were 
completely negative for WWOX expression; when 
weakly WWOX expressing cases were included with  
negative cases the significance increased. Methylation 
of regulatory sequences in WWOX exon 1 distinguish 
breast cancer DNA from normal DNA and DNA from 
adjacent tissue. Treatment with 5'-Aza-2'-deoxycytidine 
to demethylate the WWOX promoter successfully 
restored WWOX expression in WWOX-deficient 
breast cancer cells. 
Prognosis 
In a sampling of 132 breast cancer tissues, high level 
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